Krueger, J. G., Kim, B. S., Weidinger, S., Kataoka, Y., O'Malley, J. T., Yen, K., . . . Vela, J. In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody. Medical Journals Sweden.
Chicago Style (17th ed.) CitationKrueger, James G., Brian S. Kim, Stephan Weidinger, Yoko Kataoka, John T. O'Malley, Karl Yen, Cassie Van Krinks, and Jose Vela. In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody. Medical Journals Sweden.
MLA (9th ed.) CitationKrueger, James G., et al. In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody. Medical Journals Sweden.
Warning: These citations may not always be 100% accurate.